Kissei Pharmaceutical Co (TSE:4547) Cyclically Adjusted PS Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4547 Kissei Pharmaceutical Co Ltd TSE:4547
77 GF Score
Price 円4,005.00
GF Value 円4,660.25
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Kissei Pharmaceutical Co Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Kissei Pharmaceutical Co  (TSE:4547) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Kissei Pharmaceutical Co Cyclically Adjusted PS Ratio Related Terms


Kissei Pharmaceutical Co Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Kissei Pharmaceutical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kissei Pharmaceutical Co Cyclically Adjusted PS Ratio Chart

Kissei Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.75 1.74 2.23 2.29 2.63

Kissei Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.36 2.48 2.64 2.62 2.27

TSE:4547 vs ZTS: Cyclically Adjusted PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kissei Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kissei Pharmaceutical Co Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kissei Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Kissei Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.


TSE:4547
77GF Score
Kissei Pharmaceutical Co Ltd TSE:4547
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kissei Pharmaceutical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Kissei Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Kissei Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=564.244/113.6000*113.6000
=564.244

Current CPI (Jun. 2026) = 113.6000.

Kissei Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 340.874 98.000 395.136
201612 386.871 98.400 446.632
201703 353.871 98.100 409.783
201706 390.078 98.500 449.877
201709 367.160 98.800 422.160
201712 417.951 99.400 477.658
201803 364.626 99.200 417.556
201806 382.246 99.200 437.733
201809 381.344 99.900 433.640
201812 419.275 99.700 477.730
201903 364.819 99.700 415.681
201906 344.850 99.800 392.535
201909 330.719 100.100 375.321
201912 363.963 100.500 411.405
202003 314.281 100.300 355.955
202006 343.822 99.900 390.973
202009 347.225 99.900 394.842
202012 426.192 99.300 487.567
202103 362.260 99.900 411.939
202106 360.729 99.500 411.847
202109 341.596 100.100 387.665
202112 383.751 100.100 435.506
202203 331.687 101.100 372.697
202206 353.139 101.800 394.073
202209 359.508 103.100 396.121
202212 407.042 104.100 444.188
202303 343.875 104.400 374.178
202306 419.656 105.200 453.165
202309 385.585 106.200 412.453
202312 464.659 106.800 494.244
202403 400.473 107.200 424.382
202406 478.766 108.200 502.660
202409 481.889 108.900 502.687
202412 534.047 110.700 548.037
202503 529.400 111.100 541.313
202506 529.716 111.700 538.726
202509 570.290 112.000 578.437
202512 646.578 113.000 650.011
202603 597.631 112.700 602.404
202606 564.244 113.600 564.244

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Kissei Pharmaceutical Co (TSE:4547) Overvalued in 2026?

Based on GuruFocus' analysis, Kissei Pharmaceutical Co stock appears to be undervalued. The current stock price of 円4,005.00 is trading 14.1% below its estimated GF Value™ of 円4,660.25. GuruFocus considers Kissei Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for TSE:4547:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: 円4,660.25 vs. price of 円4,005.00 (14.1% below fair value)
  • GF Score™: 77/100 with 1 warning sign

No single metric tells the full story. See the TSE:4547 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kissei Pharmaceutical Co Business Description

Address 19-48, Yoshino, Matsumoto City, Nagano, JPN, 399-8710
Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
77GF Score

Get the complete analysis for TSE:4547

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円4,005.00
Price
円4,660.25
GF Value